Professional Documents
Culture Documents
PRO/07
Approved by: Signature:
General Manager
-------------------------------------------
Original date: Version: Next Review Due on:
25th October 2021 1st 25th October 2022
PURPOSE
The purpose of this procedure is to describe the sequence of events that take
place when an adverse event is reported, its investigation and the steps taken to
prevent the recurrence of the adverse event in the future.
Definition
1
This procedure is applicable to all the adverse events that are reported to the
company “Ammar Optician Company W.L.L”.
RESPONSIBILTIES
PROCEDURE
An adverse event may be reported via any communication channel from the end
user. The office department staff will receive and initiate the investigation into
the adverse event after logging it in the adverse event reporting form.
The adverse event complaint will be followed by the following steps:
When it has been identified that the adverse event is one that needs to
be reported to NHRA, then NHRA will be promptly informed by
submitting “Medical Devices Reporting form” including all details and
information related to it.
All details relating to adverse event are recorded accurately; including
date, time, and the medical device name, model, serial / lot number.
2
The devices involved in the adverse event would be kept in quarantine in
a separate area in the storage, where practicable, until all involved
parties, including NHRA, have been consulted and the investigation is
completed.
NHRA and the manufacturer will be informed within the below mentioned
period:
within 10 working days for Death/Serious Injury
within 30 working days for minor injury/other problems
The office department staff , with the assistance of the maintenance team an
branch managers, shall lead the investigation if the adverse event is regarding
medical device failure/breakage/calibration.
The office department staff, with the assistance of the storekeeper and branch
managers, will lead the investigation of the adverse event if it is related to
faulty or expired products.
Formation of a committee will take place, comprising of the office staff,
maintenance team and storekeeper where they will discuss the adverse event
occurrence, it’s reason and put forward a suitable corrective action to prevent
repetition in the future.
At the end of the investigation, a detailed report with the findings, corrective
actions, along with the preventive measures, will be submitted to the end user
and the company will retain its copy.
All the adverse events will be reported to the National Health Regulatory
Authority (NHRA), along with the necessary documents, pictures and actions
implemented to rectify the situation and to prevent the recurrences.
A copy of details of the report will be added in the software tool DOTLINE
TECHNOLOGY that can be traced and accessed later on. If it is not the first time
for the same product/device, then the company will report to NHRA to take the
suitable action like recalling the product (Please refer to Recall policy for
further details).
If NHRA issues a recall notice because of the adverse events, then the company
will issue recall notices to all its end users/customers to whom the
products/devices have been supplied to in the Kingdom of Bahrain
For returned goods, that have been recalled from the market after the adverse
events reporting, they will be traced and assessed by the storekeeper, by using
DOTLINE TECHNOLOGY, against the batch numbers, serial numbers and expiry
provided by the manufacturer and shipment.
The recalled devices/products, which will be returned after the adverse event,
will be considered as “Non acceptable returned goods” and a label of “For
Recall- Quarantine” will be affixed to them and they will be moved to an
isolated area in the store so that they are not mixed up with the regular goods.
(Please refer to Policy for Recall for details)
3
Rejected goods shall be destroyed, after the approval of NHRA, in a way it will
not cause any harm to any individual or the environment.
All records of destruction of goods shall be maintained by the company.
REVIEW
This policy shall be reviewed on an annual basis for any modifications and
iterations in the process.
ATTACHMENT
4
Medical device/Product:
Date of Expiry
Serial Number:
FSN No.
Reason:
Medical device/Product:
Date of Expiry
Serial Number:
Quantity:
5
Medical device/Product:
Date of Expiry
Serial Number:
Quantity: